Investor Slashes Million From Zymeworks as Stock Jumps 60%
A large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
Findings from the Budget Calculator guide you in prioritizing goals and shaping a realistic plan. Use them to steer your financial journey.
20,466 articlesA large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
A 2.8% cost-of-living bump boosts checks in January, but higher Medicare costs and a government scheduling overhaul m...
The market loves dramatic headlines about AI threatening legacy tech, but the real story is nuanced. This piece expla...
Investors are buzzing about a potential silver surge. This guide breaks down the chances of american silver going $70...
A soon-to-retire investor outlines a simple, income-centric ETF strategy built around three funds—JEPQ, DIVO, and SPH...
Oracle confronts a heavy debt burden and sweeping layoffs as it presses ahead with a three-step transformation, raisi...
In a $520 billion, fragmented remodeling market, larger players use scale and financing access to win more projects, ...
Planning to use leveraged exposure to the S&P 500? This guide compares SPXL and SSO, explaining how each ETF magnifie...
Waterbridge's 2025 earnings narrative offers insight into growth drivers, cash flow, and capital allocation. This ana...
A fresh ETF blends SCHD with an options overlay to target about twice the underlying yield. The approach promises hig...
A high-profile fund sold a sizable GRAIL stake right before a dramatic 50% one-day drop. This article unpacks the mov...
An insurer’s blockbuster profit alongside an insider stock sale creates a compelling investing puzzle. This article b...